Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Related Post
10 December, 2025
Shaping the future: How TROG’s Emerging Investigators group is breaking down barriers for new researchers
SPECIAL INTEREST GROUP IN FOCUS: 10 December 2025 Dr
9 December, 2025
TROG’s inaugural Km’s for Cancer Research brings community together to support our work
LATEST NEWS: 9 December 2025 As we wrap up